PDB Short entry for 4B3Q HEADER HYDROLASE/DNA/RNA 25-JUL-12 4B3Q TITLE STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT TITLE 2 CONFORMATION AND SUBSTRATE INTERFACE COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EXORIBONUCLEASE H, P66 RT, REVERSE TRANSCRIPTASE P66 COMPND 5 SUBUNIT; COMPND 6 EC: 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2, 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: P51 RT; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: REVERSE TRANSCRIPTASE P51 SUBUNIT; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: PRIMER DNA; COMPND 17 CHAIN: D; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 4; COMPND 20 MOLECULE: TEMPLATE RNA; COMPND 21 CHAIN: R; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 1007065; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: M15; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PDMI.1; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 11 ORGANISM_TAXID: 11676; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 1007065; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: M15; SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 16 EXPRESSION_SYSTEM_VECTOR: PDMI.1; SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES; SOURCE 19 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 20 ORGANISM_TAXID: 32630; SOURCE 21 MOL_ID: 4; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 24 ORGANISM_TAXID: 32630 KEYWDS HYDROLASE-DNA-RNA COMPLEX, RNASE H, HYBRID EXPDTA X-RAY DIFFRACTION AUTHOR M.LAPKOUSKI,L.TIAN,J.T.MILLER,S.F.J.LE GRICE,W.YANG REVDAT 5 20-DEC-23 4B3Q 1 REMARK SEQRES REVDAT 4 06-MAR-19 4B3Q 1 SOURCE REMARK REVDAT 3 20-FEB-13 4B3Q 1 JRNL REVDAT 2 23-JAN-13 4B3Q 1 JRNL REVDAT 1 16-JAN-13 4B3Q 0 JRNL AUTH M.LAPKOUSKI,L.TIAN,J.T.MILLER,S.F.J.LE GRICE,W.YANG JRNL TITL COMPLEXES OF HIV-1 RT, NNRTI AND RNA/DNA HYBRID REVEAL A JRNL TITL 2 STRUCTURE COMPATIBLE WITH RNA DEGRADATION JRNL REF NAT.STRUCT.MOL.BIOL. V. 20 230 2013 JRNL REFN ISSN 1545-9993 JRNL PMID 23314251 JRNL DOI 10.1038/NSMB.2485 REMARK 2 REMARK 2 RESOLUTION. 5.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 5.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.8 REMARK 3 NUMBER OF REFLECTIONS : 13005 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.363 REMARK 3 R VALUE (WORKING SET) : 0.361 REMARK 3 FREE R VALUE : 0.407 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 662 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.9871 - 8.4983 0.98 2772 132 0.3050 0.3815 REMARK 3 2 8.4983 - 6.7709 0.96 2648 135 0.3810 0.3910 REMARK 3 3 6.7709 - 5.9225 0.90 2435 152 0.4222 0.4532 REMARK 3 4 5.9225 - 5.3844 0.85 2327 115 0.4300 0.4145 REMARK 3 5 5.3844 - 5.0003 0.80 2161 128 0.4427 0.4691 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 1.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 49.260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 170.3 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 149.0 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 8737 REMARK 3 ANGLE : 0.802 12103 REMARK 3 CHIRALITY : 0.054 1370 REMARK 3 PLANARITY : 0.004 1384 REMARK 3 DIHEDRAL : 13.780 3303 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4B3Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1290053439. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUL-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED REMARK 200 SI(111) REMARK 200 OPTICS : ADJUSTABLE FOCUS K-B PAIR SI REMARK 200 MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH MAR300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14646 REMARK 200 RESOLUTION RANGE HIGH (A) : 5.000 REMARK 200 RESOLUTION RANGE LOW (A) : 60.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.14000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 5.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 5.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.87000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRIES 1RTD, 1FK9 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 82.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 6.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RT COMPLEX WAS MIXED WITH RESERVOIR REMARK 280 SOLUTION CONTAINING 1.8M (NH4)2SO4, 50MM TRIS HCL (PH8.5), AND REMARK 280 25MM MGSO4. VAPOR DIFFUSION 4C., TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 7555 X+2/3,Y+1/3,Z+1/3 REMARK 290 8555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 9555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 10555 Y+2/3,X+1/3,-Z+1/3 REMARK 290 11555 X-Y+2/3,-Y+1/3,-Z+1/3 REMARK 290 12555 -X+2/3,-X+Y+1/3,-Z+1/3 REMARK 290 13555 X+1/3,Y+2/3,Z+2/3 REMARK 290 14555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 15555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 16555 Y+1/3,X+2/3,-Z+2/3 REMARK 290 17555 X-Y+1/3,-Y+2/3,-Z+2/3 REMARK 290 18555 -X+1/3,-X+Y+2/3,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 136.35000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 78.72171 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 77.70000 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 136.35000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 78.72171 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 77.70000 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 136.35000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 78.72171 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 77.70000 REMARK 290 SMTRY1 10 -0.500000 0.866025 0.000000 136.35000 REMARK 290 SMTRY2 10 0.866025 0.500000 0.000000 78.72171 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 77.70000 REMARK 290 SMTRY1 11 1.000000 0.000000 0.000000 136.35000 REMARK 290 SMTRY2 11 0.000000 -1.000000 0.000000 78.72171 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 77.70000 REMARK 290 SMTRY1 12 -0.500000 -0.866025 0.000000 136.35000 REMARK 290 SMTRY2 12 -0.866025 0.500000 0.000000 78.72171 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 77.70000 REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 157.44342 REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 155.40000 REMARK 290 SMTRY1 14 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 14 0.866025 -0.500000 0.000000 157.44342 REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 155.40000 REMARK 290 SMTRY1 15 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 15 -0.866025 -0.500000 0.000000 157.44342 REMARK 290 SMTRY3 15 0.000000 0.000000 1.000000 155.40000 REMARK 290 SMTRY1 16 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 16 0.866025 0.500000 0.000000 157.44342 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 155.40000 REMARK 290 SMTRY1 17 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 17 0.000000 -1.000000 0.000000 157.44342 REMARK 290 SMTRY3 17 0.000000 0.000000 -1.000000 155.40000 REMARK 290 SMTRY1 18 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 18 -0.866025 0.500000 0.000000 157.44342 REMARK 290 SMTRY3 18 0.000000 0.000000 -1.000000 155.40000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 52220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -69.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, R REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 62 REMARK 465 ILE A 63 REMARK 465 LYS A 64 REMARK 465 LYS A 65 REMARK 465 LYS A 66 REMARK 465 ASP A 67 REMARK 465 GLY A 68 REMARK 465 THR A 69 REMARK 465 LYS A 70 REMARK 465 TRP A 71 REMARK 465 ARG A 72 REMARK 465 LYS A 73 REMARK 465 LEU A 74 REMARK 465 ARG A 557 REMARK 465 LYS A 558 REMARK 465 ILE A 559 REMARK 465 LEU A 560 REMARK 465 MET B -13 REMARK 465 ARG B -12 REMARK 465 GLY B -11 REMARK 465 SER B -10 REMARK 465 HIS B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 GLN B -1 REMARK 465 LEU B 0 REMARK 465 PRO B 1 REMARK 465 ILE B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 ILE B 5 REMARK 465 GLU B 6 REMARK 465 THR B 216 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 GLU B 432 REMARK 465 PRO B 433 REMARK 465 ILE B 434 REMARK 465 VAL B 435 REMARK 465 GLY B 436 REMARK 465 ALA B 437 REMARK 465 GLU B 438 REMARK 465 THR B 439 REMARK 465 PHE B 440 REMARK 465 DT D -1 REMARK 465 DC D 0 REMARK 465 DG D 1 REMARK 465 DT D 2 REMARK 465 A R 1 REMARK 465 U R 2 REMARK 465 G R 3 REMARK 465 A R 4 REMARK 465 N R 5 REMARK 465 A R 27 REMARK 465 C R 28 REMARK 465 G R 29 REMARK 465 A R 30 REMARK 465 C R 31 REMARK 465 C R 32 REMARK 465 A R 33 REMARK 465 C R 34 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 5 CG1 CG2 CD1 REMARK 470 LYS A 11 CG CD CE NZ REMARK 470 LYS A 20 CG CD CE NZ REMARK 470 LYS A 22 CG CD CE NZ REMARK 470 TRP A 24 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 24 CZ3 CH2 REMARK 470 GLU A 29 CG CD OE1 OE2 REMARK 470 LYS A 30 CG CD CE NZ REMARK 470 LYS A 32 CG CD CE NZ REMARK 470 GLU A 36 CG CD OE1 OE2 REMARK 470 LYS A 43 CG CD CE NZ REMARK 470 LYS A 46 CG CD CE NZ REMARK 470 PHE A 61 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 78 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 82 CG CD CE NZ REMARK 470 LYS A 83 CG CD CE NZ REMARK 470 GLN A 91 CG CD OE1 NE2 REMARK 470 ASN A 136 CG OD1 ND2 REMARK 470 ASN A 137 CG OD1 ND2 REMARK 470 GLU A 138 CG CD OE1 OE2 REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 SER A 251 OG REMARK 470 TRP A 252 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 252 CZ3 CH2 REMARK 470 GLN A 258 CG CD OE1 NE2 REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 GLU A 415 CG CD OE1 OE2 REMARK 470 LYS A 424 CG CD CE NZ REMARK 470 ARG A 448 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 512 CG CD OE1 NE2 REMARK 470 SER A 515 OG REMARK 470 LYS B 65 CG CD CE NZ REMARK 470 LYS B 66 CG CD CE NZ REMARK 470 ASP B 67 CG OD1 OD2 REMARK 470 LYS B 70 CG CD CE NZ REMARK 470 ARG B 72 CB CG CD NE CZ NH1 NH2 REMARK 470 LYS B 82 CG CD CE NZ REMARK 470 LYS B 83 CG CD CE NZ REMARK 470 TRP B 88 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 88 CZ3 CH2 REMARK 470 GLU B 89 CG CD OE1 OE2 REMARK 470 LYS B 103 CG CD CE NZ REMARK 470 ASN B 137 CG OD1 ND2 REMARK 470 LYS B 166 CG CD CE NZ REMARK 470 PHE B 171 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 172 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 173 CG CD CE NZ REMARK 470 HIS B 198 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 199 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 206 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 207 CG CD OE1 NE2 REMARK 470 ARG B 211 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 358 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 374 CG CD CE NZ REMARK 470 TRP B 410 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 410 CZ3 CH2 REMARK 470 LYS B 431 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 2 -34.17 -134.44 REMARK 500 GLU A 6 108.45 36.33 REMARK 500 GLU A 28 -40.37 71.67 REMARK 500 MET A 184 -86.57 52.17 REMARK 500 GLU A 248 76.85 -119.27 REMARK 500 LYS A 249 -70.30 -147.96 REMARK 500 THR A 253 -158.70 45.24 REMARK 500 LYS A 287 76.11 57.27 REMARK 500 VAL A 292 91.33 59.13 REMARK 500 PHE A 346 -37.36 70.13 REMARK 500 LEU A 349 -62.05 -96.20 REMARK 500 ASN A 363 130.37 69.42 REMARK 500 THR A 450 -14.16 65.79 REMARK 500 LYS A 451 71.06 58.91 REMARK 500 ASP A 471 73.94 54.11 REMARK 500 ASP A 488 56.49 -101.57 REMARK 500 ASP A 511 83.38 -153.97 REMARK 500 HIS A 539 80.23 55.75 REMARK 500 LYS A 540 -44.31 -146.86 REMARK 500 THR B 69 51.61 33.33 REMARK 500 GLU B 89 -51.07 -132.61 REMARK 500 MET B 184 -95.26 54.23 REMARK 500 TRP B 239 45.08 -92.84 REMARK 500 ALA B 355 -87.84 -78.99 REMARK 500 ALA B 360 -87.34 -118.59 REMARK 500 TRP B 383 -70.17 -109.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NVP A 999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A30 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH A TRIPEPTIDE INHIBITOR REMARK 900 RELATED ID: 1BV7 RELATED DB: PDB REMARK 900 COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS REMARK 900 OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA REMARK 900 AMIDES WITH BROAD SPECIFICITIES REMARK 900 RELATED ID: 1BV9 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS REMARK 900 RELATED ID: 1BVE RELATED DB: PDB REMARK 900 HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES REMARK 900 RELATED ID: 1BVG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE REMARK 900 STRUCTURE REMARK 900 RELATED ID: 1BWA RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF REMARK 900 DUPONT PHARMACEUTICALS REMARK 900 RELATED ID: 1BWB RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF REMARK 900 DUPONT PHARMACEUTICALS REMARK 900 RELATED ID: 1C0T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+ REMARK 900 21.1326 REMARK 900 RELATED ID: 1C0U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+ REMARK 900 50.0934 REMARK 900 RELATED ID: 1C1B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 GCA- 186 REMARK 900 RELATED ID: 1C1C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 TNK- 6123 REMARK 900 RELATED ID: 1DMP RELATED DB: PDB REMARK 900 STRUCTURE OF HIV-1 PROTEASE COMPLEX REMARK 900 RELATED ID: 1DTQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 PETT-1 (PETT131A94) REMARK 900 RELATED ID: 1DTT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 PETT-2 (PETT130A94) REMARK 900 RELATED ID: 1E6J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH REMARK 900 FAB13B5 REMARK 900 RELATED ID: 1EP4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S- REMARK 900 1153 REMARK 900 RELATED ID: 1ESK RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF NCP7 FROM HIV-1 REMARK 900 RELATED ID: 1EX4 RELATED DB: PDB REMARK 900 HIV-1 INTEGRASE CATALYTIC CORE AND C-TERMINAL DOMAIN REMARK 900 RELATED ID: 1EXQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 INTEGRASE CATALYTIC COREDOMAIN REMARK 900 RELATED ID: 1FB7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT INCOMPLEX REMARK 900 WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OFDRUG RESISTANCE REMARK 900 RELATED ID: 1FK9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH DMP- REMARK 900 266(EFAVIRENZ) REMARK 900 RELATED ID: 1FKO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV- 1REVERSE REMARK 900 TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ) REMARK 900 RELATED ID: 1FKP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV- 1REVERSE REMARK 900 TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1G6L RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF TETHERED HIV-1 PROTEASE REMARK 900 RELATED ID: 1HIV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WITH U75875 (NOA- HIS-CHA- REMARK 900 PSI[CH(OH)CH(OH)]VAL-ILE-APY) REMARK 900 RELATED ID: 1HVH RELATED DB: PDB REMARK 900 NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS REMARK 900 RELATED ID: 1HVR RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) PROTEASE COMPLEXED WITH REMARK 900 XK263 OF DUPONT MERCK REMARK 900 RELATED ID: 1HWR RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS REMARK 900 RELATED ID: 1HXB RELATED DB: PDB REMARK 900 HIV-1 PROTEINASE COMPLEXED WITH RO 31-8959 REMARK 900 RELATED ID: 1JKH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH DMP-266(EFAVIRENZ) REMARK 900 RELATED ID: 1JLA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH TNK-651 REMARK 900 RELATED ID: 1JLB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1JLC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH PETT-2 REMARK 900 RELATED ID: 1JLE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSETRANSCRIPTASE REMARK 900 RELATED ID: 1JLF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1JLG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH UC-781 REMARK 900 RELATED ID: 1JLQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 739W94 REMARK 900 RELATED ID: 1KLM RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U- 90152 REMARK 900 RELATED ID: 1LV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE NON-ACTIVE SITE MUTANT OFTETHERED REMARK 900 HIV-1 PROTEASE TO 2.1A RESOLUTION REMARK 900 RELATED ID: 1LW0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1LW2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH 1051U91 REMARK 900 RELATED ID: 1LWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1LWE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSETRANSCRIPTASE REMARK 900 (RTMN) IN COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1LWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE(RTMQ+ REMARK 900 M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITHNEVIRAPINE REMARK 900 RELATED ID: 1NCP RELATED DB: PDB REMARK 900 RELATED ID: 1O1W RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE RNASE H DOMAIN OF THE HIV -1REVERSE REMARK 900 TRANSCRIPTASE IN THE PRESENCE OF MAGNESIUM REMARK 900 RELATED ID: 1ODW RELATED DB: PDB REMARK 900 NATIVE HIV-1 PROTEINASE REMARK 900 RELATED ID: 1ODY RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130 REMARK 900 RELATED ID: 1QBR RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1QBS RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1QBT RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1QBU RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1REV RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1RT1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC- REMARK 900 442 REMARK 900 RELATED ID: 1RT2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK- REMARK 900 651 REMARK 900 RELATED ID: 1RT3 RELATED DB: PDB REMARK 900 AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH REMARK 900 1051U91 REMARK 900 RELATED ID: 1RT4 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781 REMARK 900 RELATED ID: 1RT5 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10 REMARK 900 RELATED ID: 1RT6 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38 REMARK 900 RELATED ID: 1RT7 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84 REMARK 900 RELATED ID: 1RTD RELATED DB: PDB REMARK 900 STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: REMARK 900 IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE REMARK 900 RELATED ID: 1RTH RELATED DB: PDB REMARK 900 RELATED ID: 1RTI RELATED DB: PDB REMARK 900 RELATED ID: 1RTJ RELATED DB: PDB REMARK 900 RELATED ID: 1S1T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH UC-781 REMARK 900 RELATED ID: 1S1U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1S1V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH TNK-651 REMARK 900 RELATED ID: 1S1W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH UC-781 REMARK 900 RELATED ID: 1S1X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1T05 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE- PRIMERWITH REMARK 900 TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE REMARK 900 RELATED ID: 1TAM RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS, NMR, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1TKT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW426318 REMARK 900 RELATED ID: 1TKX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW490745 REMARK 900 RELATED ID: 1TKZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW429576 REMARK 900 RELATED ID: 1TL1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW451211 REMARK 900 RELATED ID: 1TL3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW450557 REMARK 900 RELATED ID: 1VRT RELATED DB: PDB REMARK 900 RELATED ID: 1VRU RELATED DB: PDB REMARK 900 RELATED ID: 2WHH RELATED DB: PDB REMARK 900 HIV-1 PROTEASE TETHERED DIMER Q-PRODUCT COMPLEX ALONG WITH REMARK 900 NUCLEOPHILIC WATER MOLECULE REMARK 900 RELATED ID: 2WOM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE REMARK 900 (K103N). REMARK 900 RELATED ID: 2WON RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE REMARK 900 (WILD-TYPE). REMARK 900 RELATED ID: 3PHV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (ISOLATE HXB2) REMARK 900 RELATED ID: 4B37 RELATED DB: PDB REMARK 900 STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT REMARK 900 CONFORMATION AND SUBSTRATE INTERFACE REMARK 900 RELATED ID: 4B3O RELATED DB: PDB REMARK 900 STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT REMARK 900 CONFORMATION AND SUBSTRATE INTERFACE REMARK 900 RELATED ID: 4B3P RELATED DB: PDB REMARK 900 STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT REMARK 900 CONFORMATION AND SUBSTRATE INTERFACE REMARK 999 REMARK 999 SEQUENCE REMARK 999 P66 MUTATIONS S68G, R83K, I411V, N477S, R461K, Y483H, REMARK 999 D498N, V559I REMARK 999 P51 MUTATIONS S68G, R83K, I411V, N-TERMINAL MRGSHHHHHHGSQL DBREF 4B3Q A 1 560 UNP P04585 POL_HV1H2 588 1147 DBREF 4B3Q B 1 440 UNP P04585 POL_HV1H2 588 1027 DBREF 4B3Q D -1 23 PDB 4B3Q 4B3Q -1 23 DBREF 4B3Q R 1 34 PDB 4B3Q 4B3Q 1 34 SEQADV 4B3Q GLY A 68 UNP P04585 SER 655 ENGINEERED MUTATION SEQADV 4B3Q LYS A 83 UNP P04585 ARG 670 ENGINEERED MUTATION SEQADV 4B3Q VAL A 411 UNP P04585 ILE 998 ENGINEERED MUTATION SEQADV 4B3Q SER A 447 UNP P04585 ASN 1034 ENGINEERED MUTATION SEQADV 4B3Q LYS A 461 UNP P04585 ARG 1048 ENGINEERED MUTATION SEQADV 4B3Q HIS A 483 UNP P04585 TYR 1070 ENGINEERED MUTATION SEQADV 4B3Q ILE A 559 UNP P04585 VAL 1146 ENGINEERED MUTATION SEQADV 4B3Q MET B -13 UNP P04585 EXPRESSION TAG SEQADV 4B3Q ARG B -12 UNP P04585 EXPRESSION TAG SEQADV 4B3Q GLY B -11 UNP P04585 EXPRESSION TAG SEQADV 4B3Q SER B -10 UNP P04585 EXPRESSION TAG SEQADV 4B3Q HIS B -9 UNP P04585 EXPRESSION TAG SEQADV 4B3Q HIS B -8 UNP P04585 EXPRESSION TAG SEQADV 4B3Q HIS B -7 UNP P04585 EXPRESSION TAG SEQADV 4B3Q HIS B -6 UNP P04585 EXPRESSION TAG SEQADV 4B3Q HIS B -5 UNP P04585 EXPRESSION TAG SEQADV 4B3Q HIS B -4 UNP P04585 EXPRESSION TAG SEQADV 4B3Q GLY B -3 UNP P04585 EXPRESSION TAG SEQADV 4B3Q SER B -2 UNP P04585 EXPRESSION TAG SEQADV 4B3Q GLN B -1 UNP P04585 EXPRESSION TAG SEQADV 4B3Q LEU B 0 UNP P04585 EXPRESSION TAG SEQADV 4B3Q GLY B 68 UNP P04585 SER 655 ENGINEERED MUTATION SEQADV 4B3Q LYS B 83 UNP P04585 ARG 670 ENGINEERED MUTATION SEQADV 4B3Q VAL B 411 UNP P04585 ILE 998 ENGINEERED MUTATION SEQRES 1 A 560 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 560 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 560 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 560 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 560 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 560 LYS ASP GLY THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 560 GLU LEU ASN LYS LYS THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 560 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 560 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 560 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 560 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 560 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 560 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 560 PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 560 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 560 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 560 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 560 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 560 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 560 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 560 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 560 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 A 560 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 560 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 560 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 560 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 560 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 560 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 560 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 560 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 560 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 560 GLU TYR TRP GLN ALA THR TRP VAL PRO GLU TRP GLU PHE SEQRES 33 A 560 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 560 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 560 ASP GLY ALA ALA SER ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 560 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL THR SEQRES 37 A 560 LEU THR ASP THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 560 ILE HIS LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 560 ILE VAL THR ASN SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 560 ALA GLN PRO ASP GLN SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 560 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 560 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 560 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS ILE SEQRES 44 A 560 LEU SEQRES 1 B 454 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER GLN SEQRES 2 B 454 LEU PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU SEQRES 3 B 454 LYS PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO SEQRES 4 B 454 LEU THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS SEQRES 5 B 454 THR GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY SEQRES 6 B 454 PRO GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS SEQRES 7 B 454 LYS LYS ASP GLY THR LYS TRP ARG LYS LEU VAL ASP PHE SEQRES 8 B 454 ARG GLU LEU ASN LYS LYS THR GLN ASP PHE TRP GLU VAL SEQRES 9 B 454 GLN LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS SEQRES 10 B 454 LYS SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SEQRES 11 B 454 SER VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA SEQRES 12 B 454 PHE THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE SEQRES 13 B 454 ARG TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SEQRES 14 B 454 SER PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU SEQRES 15 B 454 GLU PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR SEQRES 16 B 454 GLN TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU SEQRES 17 B 454 ILE GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN SEQRES 18 B 454 HIS LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS SEQRES 19 B 454 HIS GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU SEQRES 20 B 454 LEU HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU SEQRES 21 B 454 PRO GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS SEQRES 22 B 454 LEU VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO SEQRES 23 B 454 GLY ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY SEQRES 24 B 454 THR LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU SEQRES 25 B 454 ALA GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS SEQRES 26 B 454 GLU PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP SEQRES 27 B 454 LEU ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP SEQRES 28 B 454 THR TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS SEQRES 29 B 454 THR GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN SEQRES 30 B 454 ASP VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR SEQRES 31 B 454 THR GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE SEQRES 32 B 454 LYS LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP SEQRES 33 B 454 THR GLU TYR TRP GLN ALA THR TRP VAL PRO GLU TRP GLU SEQRES 34 B 454 PHE VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN SEQRES 35 B 454 LEU GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE SEQRES 1 D 25 DT DC DG DT DA DT DG DC DC DT DA DT DA SEQRES 2 D 25 DG DT DT DA DT DT DG DT DG DG DC DC SEQRES 1 R 34 A U G A N G G C C A C A A SEQRES 2 R 34 U A A C U A U A G G C A U SEQRES 3 R 34 A C G A C C A C HET NVP A 999 20 HETNAM NVP 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2- HETNAM 2 NVP B:2',3'-E][1,4]DIAZEPIN-6-ONE HETSYN NVP NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE FORMUL 5 NVP C15 H14 N4 O HELIX 1 1 LYS A 30 GLY A 45 1 16 HELIX 2 2 PHE A 77 THR A 84 1 8 HELIX 3 3 ASP A 113 VAL A 118 1 6 HELIX 4 4 ASP A 121 LYS A 126 1 6 HELIX 5 5 GLY A 155 LEU A 168 1 14 HELIX 6 6 LEU A 168 ASN A 175 1 8 HELIX 7 7 GLU A 194 ARG A 211 1 18 HELIX 8 8 VAL A 254 SER A 268 1 15 HELIX 9 9 VAL A 276 LYS A 281 1 6 HELIX 10 10 LEU A 282 GLY A 285 5 4 HELIX 11 11 THR A 296 GLU A 312 1 17 HELIX 12 12 ASN A 363 ILE A 382 1 20 HELIX 13 13 GLN A 394 TYR A 405 1 12 HELIX 14 14 THR A 473 ASP A 488 1 16 HELIX 15 15 SER A 499 ALA A 508 1 10 HELIX 16 16 LEU A 517 LYS A 528 1 12 HELIX 17 17 ASN A 545 SER A 553 1 9 HELIX 18 18 THR B 27 GLY B 45 1 19 HELIX 19 19 PHE B 77 LYS B 82 1 6 HELIX 20 20 ASP B 86 LEU B 92 1 7 HELIX 21 21 GLY B 112 SER B 117 5 6 HELIX 22 22 PHE B 124 ALA B 129 5 6 HELIX 23 23 SER B 134 GLU B 138 5 5 HELIX 24 24 GLY B 155 ASN B 175 1 21 HELIX 25 25 GLU B 194 GLY B 213 1 20 HELIX 26 26 THR B 253 ALA B 267 1 15 HELIX 27 27 VAL B 276 LYS B 281 1 6 HELIX 28 28 THR B 296 GLU B 312 1 17 HELIX 29 29 VAL B 365 TRP B 383 1 19 HELIX 30 30 GLN B 394 TRP B 402 1 9 HELIX 31 31 PRO B 420 LEU B 425 1 6 SHEET 1 AA 3 ILE A 47 ILE A 50 0 SHEET 2 AA 3 ARG A 143 TYR A 146 -1 O ARG A 143 N ILE A 50 SHEET 3 AA 3 ALA A 129 THR A 131 -1 O PHE A 130 N TYR A 144 SHEET 1 AB 3 SER A 105 ASP A 110 0 SHEET 2 AB 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 AB 3 VAL A 179 TYR A 183 -1 O VAL A 179 N GLY A 190 SHEET 1 AC 4 PHE A 227 TRP A 229 0 SHEET 2 AC 4 TYR A 232 LEU A 234 -1 O TYR A 232 N TRP A 229 SHEET 3 AC 4 LYS A 238 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 4 AC 4 GLY A 316 VAL A 317 -1 O GLY A 316 N TRP A 239 SHEET 1 AD 5 LYS A 350 TYR A 354 0 SHEET 2 AD 5 GLN A 336 TYR A 342 -1 O TRP A 337 N TYR A 354 SHEET 3 AD 5 ILE A 326 GLY A 333 -1 O ILE A 326 N TYR A 342 SHEET 4 AD 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 AD 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 AE 5 GLN A 464 THR A 470 0 SHEET 2 AE 5 LEU A 452 THR A 459 -1 O GLY A 453 N LEU A 469 SHEET 3 AE 5 GLU A 438 SER A 447 -1 O TYR A 441 N VAL A 458 SHEET 4 AE 5 VAL A 493 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 AE 5 VAL A 531 TRP A 535 1 O TYR A 532 N ILE A 495 SHEET 1 BA 3 ILE B 47 SER B 48 0 SHEET 2 BA 3 ARG B 143 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 BA 3 PHE B 130 THR B 131 -1 O PHE B 130 N TYR B 144 SHEET 1 BB 2 VAL B 60 LYS B 64 0 SHEET 2 BB 2 TRP B 71 VAL B 75 -1 O ARG B 72 N ILE B 63 SHEET 1 BC 4 VAL B 179 TYR B 183 0 SHEET 2 BC 4 ASP B 186 SER B 191 -1 O ASP B 186 N TYR B 183 SHEET 3 BC 4 SER B 105 ASP B 110 -1 O SER B 105 N SER B 191 SHEET 4 BC 4 GLU B 233 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 BD 5 LYS B 347 TYR B 354 0 SHEET 2 BD 5 TRP B 337 GLU B 344 -1 O TRP B 337 N TYR B 354 SHEET 3 BD 5 ILE B 326 LYS B 331 -1 O ILE B 326 N TYR B 342 SHEET 4 BD 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 BD 5 TRP B 414 PHE B 416 1 O GLU B 415 N LEU B 391 SITE 1 AC1 8 LEU A 100 LYS A 101 LYS A 103 VAL A 106 SITE 2 AC1 8 TYR A 181 LEU A 234 HIS A 235 TYR A 318 CRYST1 272.700 272.700 233.100 90.00 90.00 120.00 H 3 2 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.003667 0.002117 0.000000 0.00000 SCALE2 0.000000 0.004234 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004290 0.00000